Clinical Trial Update: A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether taking the antihistamine cetirizine (Zyrtec) before Copaxone injections reduces injection-site reactions in people with Multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• ZYRTEC (cetirizine hydrochloride)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED